Table Of Contents
1 Introduction 19
1.1 Objectives Of The Study 19
1.2 Market Definition 19
1.3 Overview Of Europe Angioplasty Balloons Market 19
1.4 Currency And Pricing 20
1.5 Limitation 20
1.6 Markets Covered 21
2 Market Segmentation 23
2.1 Markets Covered 23
2.2 Geographic Scope 24
2.3 Years Considered For The Study 25
2.4 Currency And Pricing 25
2.5 Research Methodology 26
2.6 Primary Interviews With Key Opinion Leaders 29
2.7 Secondary Sources 30
2.8 Assumptions 30
3 Market Overview 31
3.1 Drivers 33
3.1.1 Growing Incidences Of Target Disease 33
3.1.2 New Product Innovations 34
3.1.3 Technological Advancement In Cardiovascular Disease Treatment 35
3.1.4 Rising Number Of Geriatric Population 36
3.2 Restraints 36
3.2.1 Increase In Number Of Market Players 36
3.2.2 Price Clash Due To Increase In The Number Of Market Players 37
3.3 Opportunities 38
3.3.1 Mergers And Acquisitions 38
3.3.2 Growing Number Of Angioplasty Procedure 38
3.4 Challenges 39
3.4.1 Lack Of Trained Staff 39
4 Executive Summary 40
5 Premium Insights 43
6 Europe Angioplasty Balloons Market, By Type 46
6.1 Overview 47
6.2 Plain Old Balloon Angioplasty (Poba) 49
6.3 Drug-Coated Balloon (Dcb) Angioplasty 50
6.4 Cutting Balloons 51
6.5 Scoring Balloons 52
6.6 Stent Graft Balloon Catheter 53
7 Europe Angioplasty Balloons Market, By Material 54
7.1 Overview 55
7.2 Nylon 57
7.3 Polyurethane 58
7.4 Silicone Urethane Co-Polymers 59
7.5 Other 60
8 Europe Angioplasty Balloons Market, By Balloon Type 61
8.1 Overview 62
8.2 Semi-Compliant 64
8.3 Non-Compliant 65
9 Europe Angioplasty Balloons Market, By Disease Indication 66
9.1 Overview 67
9.2 Coronary Angioplasty 69
9.3 Peripheral Angioplasty 70
9.4 Carotid Angioplasty 71
9.5 Renal Artery Angioplasty 72
9.6 Venous Angioplasty 73
10 Europe Angioplasty Balloons Market, By End User 74
10.1 Overview 75
10.2 Ambulatory Surgical Centers 77
10.3 Hospitals 78
10.4 Specialty Clinics 79
10.5 Diagnostic Centers 80
10.6 Cath Lab 81
11 Europe Angioplasty Balloons Market By Geography 82
11.1 Europe 82
11.1.1 Germany 91
11.1.2 U.K. 94
11.1.3 France 97
11.1.4 Spain 100
11.1.5 Italy 103
11.1.6 Belgium 106
11.1.7 Netherlands 109
11.1.8 Switzerland 112
11.1.9 Russia 115
11.1.10 Turkey 118
11.1.11 Rest Of Europe 121
12 Europe Angioplasty Balloons Market, Company Landscape 122
12.1 Company Share Analysis; Europe 122
13 Company Profiles 123
13.1 Medtronic 123
13.1.1 Company Overview 123
13.1.2 Revenue Analysis 123
13.1.3 Company Share Analysis (%) 124
13.1.4 Product Portfolio 124
13.1.5 Recent Developments 125
13.2 C. R. Bard, Inc. (Part Of Becton, Dickinson And Company) 126
13.2.1 Company Overview 126
13.2.2 Geographic Presence 126
13.2.3 Company Share Analysis (%) 127
13.2.4 Product Portfolio 127
13.2.5 Recent Developments 128
13.3 Boston Scientific Corporation 129
13.3.1 Company Overview 129
13.3.2 Revenue Analysis 129
13.3.3 Company Share Analysis (%) 130
13.3.4 Product Portfolio 130
13.3.5 Recent Developments 131
13.4 Abbott Laboratories 132
13.4.1 Company Overview 132
13.4.2 Revenue Analysis 132
13.4.3 Product Portfolio 133
13.4.4 Recent Developments 133
13.5 Angiodynamics, Inc. 134
13.5.1 Company Overview 134
13.5.2 Revenue Analysis 134
13.5.3 Product Portfolio 135
13.5.4 Recent Developments 135
13.6 B. Braun Melsungen Ag 136
13.6.1 Company Overview 136
13.6.2 Revenue Analysis 136
13.6.3 Product Portfolio 137
13.6.4 Recent Developments 137
13.7 Biomerics, Llc 138
13.7.1 Company Overview 138
13.7.2 Geographic Presence 138
13.7.3 Product Portfolio 139
13.7.4 Recent Developments 139
13.8 Biotronik Se & Co. Kg 140
13.8.1 Company Overview 140
13.8.2 Geographic Presence 140
13.8.3 Product Portfolio 141
13.8.4 Recent Developments 141
13.9 Cook Medical Incorporated 142
13.9.1 Company Overview 142
13.9.2 Geographic Presence 142
13.9.3 Product Portfolio 143
13.9.4 Recent Developments 143
13.10 Cordis Corporation 144
13.10.1 Company Overview 144
13.10.2 Geogrphic Presence 144
13.10.3 Product Portfolio 145
13.10.4 Recent Developments 146
13.11 Hexacath 147
13.11.1 Company Overview 147
13.11.2 Product Portfolio 147
13.11.3 Recent Developments 147
13.12 Jotec Ag 148
13.12.1 Company Overview 148
13.12.2 Revenue Analysis 148
13.12.3 Product Portfolio 149
13.12.4 Recent Developments 149
13.13 Koninklijke Philips N.V. 150
13.13.1 Company Overview 150
13.13.2 Revenue Analysis 150
13.13.3 Product Portfolio 151
13.13.4 Recent Developments 151
13.14 Microport Scientific 152
13.14.1 Company Overview 152
13.14.2 Revenue Analysis 152
13.14.3 Product Portfolio 153
13.14.4 Recent Developments 153
13.15 Nipro Medical Corporation 154
13.15.1 Company Overview 154
13.15.2 Revenue Analysis 154
13.15.3 Product Portfolio 155
13.15.4 Recent Developments 155
13.16 Palex Medical Sa 156
13.16.1 Company Overview 156
13.16.2 Geographic Presence 156
13.16.3 Product Portfolio 157
13.16.4 Recent Developments 157
13.17 Panmed Us 158
13.17.1 Company Overview 158
13.17.2 Product Portfolio 158
13.17.3 Recent Developments 159
13.18 Stryker 160
13.18.1 Company Overview 160
13.18.2 Revenue Analysis 160
13.18.3 Product Portfolio 161
13.18.4 Recent Developments 161
13.19 Teleflex Inororated 162
13.19.1 Company Overview 162
13.19.2 Revenue Analysis 162
13.19.3 Product Portfolio 163
13.19.4 Recent Developments 163
13.20 Terumo Corporation 164
13.20.1 Company Overview 164
13.20.2 Revenue Analysis 164
13.20.3 Product Portfolio 165
13.20.4 Recent Developments 166
14 Latest Reports 167
?